In vitro activity of 3 commercial bacteriophage cocktails against salmonella and shigella spp. Isolates of human origin

11Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Background: Salmonella and Shigella spp. are 2 of the most frequent and deadly enteric bacterial pathogens recorded worldwide. In developing countries Salmonella infections are responsible for many deaths annually and these mortality rates are prone to increase due to the emergence of resistance to antibiotics. In this overall scenario new alternative therapeutic approaches are needed. Methods: For the first time, we investigated the activity of 3 commercial bacteriophage cocktails (INTESTI, Septaphage, PYO) against a collection of contemporary Salmonella spp. (n = 30) and Shigella spp. (n = 20) strains isolated in Switzerland. Phage susceptibility was determined by im-plementing the spot test. Results: The overall susceptibility of Salmonella spp. to INTESTI and Septaphage was 87% and 77%, respectively. With regard to Shigella spp., the overall susceptibility to INTESTI and Septa-phage was 95% and 55%, respectively. PYO was observed to be active against only 10% of Salmonella spp. but against 95% of Shigella spp. Conclusions: Our results seem promising, especially for the INTESTI biopreparation against Salmonella enterica infections. Nevertheless, such speculation should be supported by further in vivo studies to confirm efficacy and safety of the cocktails. We also emphasize the importance of large in vitro screening analyses aimed to assess the activity of such biopreparations against contemporary multidrug-resistant strains that are emerging worldwide.

References Powered by Scopus

Foodborne illness acquired in the United States-Major pathogens

6243Citations
N/AReaders
Get full text

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study

2777Citations
N/AReaders
Get full text

Revenge of the phages: Defeating bacterial defences

523Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Unlocking the next generation of phage therapy: the key is in the receptors

93Citations
N/AReaders
Get full text

Bacteriophages as potential tools for detection and control of salmonella spp. In food systems

37Citations
N/AReaders
Get full text

A New Phage Cocktail against Multidrug, ESBL-Producer Isolates of Shigella sonnei and Shigella flexneri with Highly Efficient Bacteriolytic Activity

22Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bernasconi, O. J., Donà, V., Tinguely, R., & Endimiani, A. (2018). In vitro activity of 3 commercial bacteriophage cocktails against salmonella and shigella spp. Isolates of human origin. Pathogens and Immunity, 3(1), 72–81. https://doi.org/10.20411/pai.v3i1.234

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

40%

Researcher 4

40%

Professor / Associate Prof. 1

10%

Lecturer / Post doc 1

10%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 6

46%

Agricultural and Biological Sciences 4

31%

Immunology and Microbiology 2

15%

Chemistry 1

8%

Save time finding and organizing research with Mendeley

Sign up for free